Astrana Health (ASTH) Receivables - Other (2011 - 2026)

Astrana Health has disclosed Receivables - Other across 16 years of filings, most recently posting $28.0 million for Q1 2026.

• Receivables - Other for Q1 2026 came in at $28.0 million, up 87.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.0 million (up 87.79% YoY), and the FY2025 annual result was $26.4 million, down 10.55% from the prior year.
• Receivables - Other came in at $28.0 million for Q1 2026 at Astrana Health, up from $26.4 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $91.2 million in Q3 2022 to a low of $1.1 million in Q3 2024.
• The 5-year median for Receivables - Other is $11.6 million (2022), against an average of $19.4 million.
• Across the five-year window, Receivables - Other slumped 98.35% in 2023 and surged 2109.44% in 2024, its largest moves.
• Astrana Health's Receivables - Other stood at $11.6 million in 2022, then tumbled by 88.49% to $1.3 million in 2023, then soared by 2109.44% to $29.5 million in 2024, then retreated by 10.55% to $26.4 million in 2025, then advanced by 6.19% to $28.0 million in 2026.
• The last three Receivables - Other figures came in at $28.0 million (Q1 2026), $26.4 million (Q4 2025), and $9.9 million (Q3 2025), per Business Quant data.